Lisa Evoli's most recent trade in Catalent Inc. was a trade of 3,859 Common Stock done at an average price of $59.7 . Disclosure was reported to the exchange on Aug. 2, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Catalent Inc. | Lisa Evoli | SVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 59.67 per share. | 02 Aug 2024 | 3,859 | 39,366 (0%) | 0% | 59.7 | 230,267 | Common Stock |
Catalent Inc. | Lisa Evoli | SVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 15,338 | 43,225 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 6,201 | 6,201 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 2,532 | 21,137 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.61 per share. | 10 Mar 2023 | 659 | 18,746 (0%) | 0% | 52.6 | 34,670 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 483 | 20,654 (0%) | 0% | 52.9 | 25,536 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 448 | 19,929 (0%) | 0% | 52.9 | 23,686 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.61 per share. | 10 Mar 2023 | 300 | 18,446 (0%) | 0% | 52.6 | 15,783 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 277 | 20,377 (0%) | 0% | 52.9 | 14,645 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 269 | 19,660 (0%) | 0% | 52.9 | 14,222 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 255 | 19,405 (0%) | 0% | 52.9 | 13,482 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Sale of securities on an exchange or to another person at price $ 57.00 per share. | 27 Feb 2023 | 3,767 | 18,605 (0%) | 0% | 57.0 | 214,731 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 1,552 | 19,549 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 1,137 | 22,372 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 1,054 | 21,235 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 632 | 20,181 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 55.81 per share. | 10 Aug 2022 | 1,165 | 17,997 (0%) | 0% | 55.8 | 65,020 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.34 per share. | 03 Aug 2022 | 293 | 19,162 (0%) | 0% | 55.3 | 16,215 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.87 per share. | 01 Aug 2022 | 456 | 19,455 (0%) | 0% | 56.9 | 25,933 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 55.93 per share. | 15 Jun 2022 | 900 | 19,911 (0%) | 0% | 55.9 | 50,337 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 59.85 per share. | 24 May 2022 | 250 | 20,811 (0%) | 0% | 59.9 | 14,963 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 7,680 | 23,713 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 5,553 | 5,553 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 1,975 | 16,033 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 704 | 21,061 (0%) | 0% | 65.1 | 45,837 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 657 | 22,498 (0%) | 0% | 65.1 | 42,777 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 430 | 21,765 (0%) | 0% | 65.1 | 27,997 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 394 | 23,155 (0%) | 0% | 65.1 | 25,653 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 188 | 22,310 (0%) | 0% | 65.1 | 12,241 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 164 | 23,549 (0%) | 0% | 65.1 | 10,678 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 115 | 22,195 (0%) | 0% | 65.1 | 7,488 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 67.03 per share. | 28 Feb 2022 | 1,254 | 14,058 (0%) | 0% | 67.0 | 84,056 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 3,830 | 15,312 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 2,566 | 11,482 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 1,566 | 8,916 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.39 per share. | 01 Aug 2021 | 286 | 7,539 (0%) | 0% | 72.4 | 20,704 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.62 per share. | 01 Aug 2021 | 189 | 7,350 (0%) | 0% | 70.6 | 13,347 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 10 May 2021 | 2,745 | 7,825 (0%) | 0% | 75 | 205,875 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.91 per share. | 10 May 2021 | 2,745 | 10,570 (0%) | 0% | 55.9 | 153,473 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 2,745 | 2,746 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.39 per share. | 10 May 2021 | 2,590 | 10,415 (0%) | 0% | 43.4 | 112,380 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 10 May 2021 | 2,590 | 7,825 (0%) | 0% | 75 | 194,250 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 2,590 | 7,771 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.23 per share. | 14 Apr 2021 | 3,440 | 11,265 (0%) | 0% | 56.2 | 193,431 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2021 | 3,440 | 1,147 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 14 Apr 2021 | 3,440 | 7,825 (0%) | 0% | 70 | 240,800 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2021 | 1,785 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 14 Apr 2021 | 1,785 | 7,825 (0%) | 0% | 70 | 124,950 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.68 per share. | 14 Apr 2021 | 1,785 | 9,610 (0%) | 0% | 43.7 | 77,969 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 14 Apr 2021 | 1,081 | 7,825 (0%) | 0% | 70 | 75,670 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 5,472 | 5,472 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 1,815 | 9,317 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 188 | 9,017 (0%) | 0% | 68.1 | 12,803 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 112 | 9,205 (0%) | 0% | 68.1 | 7,627 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 111 | 8,906 (0%) | 0% | 68.1 | 7,559 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 4,424 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 51.00 per share. | 09 Nov 2020 | 4,424 | 7,502 (0%) | 0% | 51 | 225,624 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.58 per share. | 09 Nov 2020 | 4,424 | 11,926 (0%) | 0% | 32.6 | 144,156 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 2,552 | 1,785 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 55.18 per share. | 09 Nov 2020 | 2,552 | 7,502 (0%) | 0% | 55.2 | 140,824 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.68 per share. | 09 Nov 2020 | 2,552 | 10,054 (0%) | 0% | 43.7 | 111,471 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 51.00 per share. | 09 Nov 2020 | 754 | 7,502 (0%) | 0% | 51 | 38,454 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2020 | 2,087 | 8,256 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Lisa Evoli | EVP & Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.75 per share. | 01 Aug 2020 | 286 | 6,169 (0%) | 0% | 47.8 | 13,657 | Common Stock |
Integra Lifesciences Holdi... | Lisa Evoli | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 05 Jun 2020 | 3,475 | 6,455 (0%) | 0% | 55 | 191,125 | Common Stock |